Cancer of the Ovary

Normal ovarian development and function; the histopathology of malignant ovarian tumours; immunobiology of ovarian epithelial cancer; growth factors, oncogenes and tumour-suppressor genes; the epidemiology of ovarian cancer; hereditary/familial ovarian cancer; prognostic factors in ovarian cancer; early diagnosis of epithelial ovarian cancer; radiologic evaluation of ovarian cancer; diagnosis and staging of epithelial ovarian cancer; primary cytoreduction; second-look laparotomy in ovarian cancer; secondary cytoreduction of ovarian malignancies; central venous and intraperitoneal access in patients; with ovarian cancer; the role of radiotherapy in the management of epithelial ovarian cancer; "in vitro" evaluation of chemotherapeutic agents; dose intensity in the treatment of ovarian carcinomal drug resistance in ovarian cancer; chemotherapy in the management of celomic epithelial carcinoma of the ovary; experimental agents (non-biological) in ovarian cancer; immunotherapy of ovarian cancer; intraperitoneal chemotherapy; high-dose chemotherapy with autologous bone marrow support for the treatment of epithelial ovarian cancer; hormone therapy in ovarian cancer; complications of chemotherapy; management of early stage ovarian cancer; management of germ cell tumours of the ovary; sex cord-stromal tumours of the ovary; metastatic tumours to the ovary; epithelial ovarian tumours of low malignant potential.